Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
09/05 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
01/05 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
+0.24% | 4.72B | |
-10.80% | 3.52B | |
+8.01% | 1.63B | |
+33.72% | 1.25B | |
+22.84% | 850M | |
+82.85% | 881M | |
+16.65% | 585M | |
-25.94% | 553M | |
-.--% | 155M |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- HC Wainwright Cuts Cullinan Oncology's Price Target to $29 From $34, Maintains Buy Rating